Qualitative and quantitative detection of HIV-1 RNA by nucleic acid sequence-based amplification. 1993

B van Gemen, and T Kievits, and P Nara, and H G Huisman, and S Jurriaans, and J Goudsmit, and P Lens
Organon Teknika, Boxtel, The Netherlands.

OBJECTIVE To develop a method to detect HIV-1 viral RNA by amplifying a specific nucleic acid sequence. METHODS The nucleic acid sequence-based amplification (NASBA) method uses the simultaneous activity of avian myeloblastosis virus reverse transcriptase, T7 RNA polymerase and RNase H to amplify a specific nucleic acid target sequence. RESULTS An in vitro cultured HIV-1 stock solution was used to validate the NASBA method and determine the variation in RNA measurement. CONCLUSIONS Although NASBA is theoretically capable of specific amplification of RNA or DNA, it is most suitable for amplification of RNA, and therefore for detection of HIV-1 viral RNA.

UI MeSH Term Description Entries
D005784 Gene Amplification A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication. Amplification, Gene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D014766 Viremia The presence of viruses in the blood. Viremias
D014773 Virology The study of the structure, growth, function, genetics, and reproduction of viruses, and VIRUS DISEASES.
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

B van Gemen, and T Kievits, and P Nara, and H G Huisman, and S Jurriaans, and J Goudsmit, and P Lens
August 2010, Analytical and bioanalytical chemistry,
B van Gemen, and T Kievits, and P Nara, and H G Huisman, and S Jurriaans, and J Goudsmit, and P Lens
November 1996, Proceedings of the National Academy of Sciences of the United States of America,
B van Gemen, and T Kievits, and P Nara, and H G Huisman, and S Jurriaans, and J Goudsmit, and P Lens
November 2018, Lab on a chip,
B van Gemen, and T Kievits, and P Nara, and H G Huisman, and S Jurriaans, and J Goudsmit, and P Lens
February 2007, Analytical chemistry,
B van Gemen, and T Kievits, and P Nara, and H G Huisman, and S Jurriaans, and J Goudsmit, and P Lens
June 1996, Journal of clinical microbiology,
B van Gemen, and T Kievits, and P Nara, and H G Huisman, and S Jurriaans, and J Goudsmit, and P Lens
January 2013, Methods in molecular biology (Clifton, N.J.),
B van Gemen, and T Kievits, and P Nara, and H G Huisman, and S Jurriaans, and J Goudsmit, and P Lens
January 2003, Journal of clinical microbiology,
B van Gemen, and T Kievits, and P Nara, and H G Huisman, and S Jurriaans, and J Goudsmit, and P Lens
April 2006, Wei sheng wu xue bao = Acta microbiologica Sinica,
B van Gemen, and T Kievits, and P Nara, and H G Huisman, and S Jurriaans, and J Goudsmit, and P Lens
May 2002, Journal of virological methods,
B van Gemen, and T Kievits, and P Nara, and H G Huisman, and S Jurriaans, and J Goudsmit, and P Lens
November 2006, The Southeast Asian journal of tropical medicine and public health,
Copied contents to your clipboard!